17 Oct 2018
STAAR Surgical to Report Third Quarter Results on October 31, 2018
STAAR will host a conference call and webcast on
A taped replay of the conference call (Conference ID 7281609) will be available beginning approximately one hour after the call’s conclusion for seven days. This replay can be accessed by dialing 855-859-2056 for domestic callers and 404-537-3406 for international callers. An archived webcast will also be available at www.staar.com.
About
STAAR, which has been dedicated solely to ophthalmic surgery for over 30
years, designs, develops, manufactures and markets implantable lenses
for the eye with companion delivery systems. These lenses are intended
to provide visual freedom for patients, lessening or eliminating the
reliance on glasses or contact lenses. All of these lenses are foldable,
which permits the surgeon to insert them through a small incision.
STAAR’s lens used in refractive surgery is called an Implantable
Collamer® Lens or “ICL,” which includes the EVO Visian ICL™ product
line. More than 900,000 Visian ICLs have been implanted to date. To
learn more about the ICL go to: www.discovericl.com.
STAAR has approximately 400 full-time equivalent employees and markets
lenses in over 75 countries. Headquartered in
View source version on businesswire.com: https://www.businesswire.com/news/home/20181017005108/en/
Investors & Media
Source: